Abstract:
본명세서에는, 피부세포분화촉진용조성물과피부세포분화촉진물질의스크리닝방법이개시된다. 본발명의피부세포분화촉진용조성물은 JAB-1의발현또는활성을억제하고, 그결과서라이어신의세포핵내로의이동을억제하여, 피부세포분화를효과적으로촉진할수 있다. 따라서, 상기조성물은피부보습, 피부장벽기능강화또는아토피완화치료에효과적이다, 또한, 일측면에따른피부세포분화촉진물질스크리닝방법은, 각질형성세포에시험물질을처리하고 JAB-1의상대적발현정도를확인함으로써, 간편하고신속하며효율적으로각질세포분화촉진물질을스크리닝할수 있다.
Abstract:
The present invention relates to a composition for whitening the skin, wherein the composition contains interleukin 27 (IL-27). More specifically, the present invention relates to a skin external application composition containing IL-27 so as to control the chromogenesis of adult melanocytes in the skin so that the skin can be whitened and hyperchromatism including chloasma and lentigo can be treated.
Abstract:
The present invention relates to a skin external application composition containing SM-19712. More specifically, the skin external application composition exhibits excellent skin whitening effects by containing SM-19712, which is an antagonist of a substance P, as an active ingredient.
Abstract:
The present invention relates to a skin whitening composition including interleukin 13 (IL-13), more specifically, to a skin preparation composition for an external use, wherein the composition comprises IL-13 to suppress a generation of a pigment and differentiation of an adult melanin cell on the skin, thereby providing a skin whitening effect; and is effective in curing hyperpigmentation skin diseases such as melasma or lentigo.
Abstract:
The present invention provides a composition for skin whitening which contains wortmannin as an active ingredient. The composition for skin whitening which contains wortmannin as an active ingredient according to the present invention whitens skin by reducing melanin production, suppressing tyrosinase activation and reducing expression of melanogenesis-related gene and protein and can be widely applied to skin externals, cosmetic compositions, and pharmaceutical compositions by having stability not to have bad influence on cells.
Abstract:
The present invention provides a composition containing LY294002 for skin whitening. The composition containing LY294002 for skin whitening reduces the generation of melanin, suppresses the activity of tyrosinase, and reduces the expression of genes and protein related to the generation of melanin for whitening the skin. The composition containing LY294002 for skin whitening has stability which does not have bad influence to cells, and is capable of widely applied to a skin external application, a cosmetic composition, and a pharmaceutical composition.